Insiders · Profile

KARSEN PERRY A

Director at Intellia Therapeutics. Filing since 17 Dec 2020. CIK 0001260573

Company

Date

Role

Action

Shares

Amount

Of holding

NTLA Intellia Therapeutics, Inc.

17 Dec 2020

Director

Sold, plan not stated

88,764

$4.75M

94.7%

1 decision on file.